Page 714 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPtEr 51 Systemic Lupus Erythematosus 687

‡ Chinese d (n = 175) 58 6 31 15 54 9 29 11 58 95 81

† african american PrOFILE cohort a (n = 216) 45 33 46 46 89 16 54 60 82 97 79

Prevalence (%) of american College of rheumatology Criteria in Different Ethnic Cohorts
† Caucasian Danish f (n = 513) 48 14 43 11 67 13 45 39 67 98 98

† Caucasian Norwegian e (n = 346) 40 13 41 1 83 8 17 34 36 99 57

† Caucasian PrOFILE cohort a (n = 260) 67 12 72 57 87 9 23 42 62 97 65

‡ Caucasian USa d (n = 46) 24 24 46 7 54 4 54 26 83 83 57 c Buján S, Ordi-Ros J, et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Ann Rheum Dis 2003;62(9):859–65. d Thumboo J, Uramoto K, et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Ch

‡ Caucasian Spain c (n = 239) NA 27 29 18 71 6 23 33 55 100 NA b Vilá LM, Mayor AM, et al. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999;8(4):279–86.

† Hispanic Puerto rican b (n = 134) 72 10 77 30 67 9 30 28 77 93 NA a Alarcón GS, McGwin Jr G, et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002;11(2):95–101.

† Hispanic PrOFILE cohort a (n = 78) 64 6 59 58 91 12 59 64 85 97 83

TABLE 51.2 Malar rash Discoid rash Photosensitivity Oral/nasal ulcers Arthritis Seizure/psychosis Renal Serositis Cytopenias Antinuclear antibody Immunological † Cumulative data. ‡ Inception data. 2001;45(6):494–500.